Join the experts in this session to learn about highly relevant, clinical hot topic issues for hepatitis B management in 2025. Topics include: quantitative HBsAg testing in clinical practice; HCC risk calculators; noninvasive testing for hepatic fibrosis; and metabolic dysfunction-associated steatotic liver disease in patients with HBV infection.
Quantitative Hepatitis B Surface Antigen Testing in Clinical Practice: Different Sources of Production, Prognostic Value, and Using Results to Guide Initiation of Treatment
Scott K. Fung, MD, FRCPC, FAASLD, Presenter
Hepatitis
8:15 AM - 8:30 AM
Nov
08
2025
San Diego, CA
Noninvasive Tests to Assess Hepatic Fibrosis in Chronic Hepatitis B: Elastography, FIB-4, APRI, and ELF Score
Richard Sterling, MD, MSc, FAASLD, Presenter
Hepatitis
8:30 AM - 8:45 AM
Nov
08
2025
San Diego, CA
Hepatocellular Carcinoma Calculators in Clinical Practice: REACH-B, mPAGE, GALAD, and ALBI Scores, and Special Populations
Terry Cheuk-Fung Yip, PhD, Presenter
Hepatitis
8:45 AM - 9:00 AM
Nov
08
2025
San Diego, CA
Metabolic Dysfunction-Associated Steatotic Liver Disease and Hepatitis B Infection (Met-HBV): Epidemiology, Serologic Profile, and Histology Studies
Helena Cortez-Pinto, MD, PhD, FAASLD, Presenter
Hepatitis
9:00 AM - 9:15 AM
Nov
08
2025
San Diego, CA
Metabolic Dysfunction-Associated Steatotic Liver Disease and Hepatitis B: Clinical Management and Outcomes—Cirrhosis, Hepatocellular Carcinoma Risk, Cardiovascular Risk, and Seroclearance Rates
Mandana Khalili, MD, Presenter
Hepatitis
Objectives
Explain the clinical utility of quantitative HBsAg testing in the management of chronic hepatitis B infection.
Describe how to estimate HCC risk in patients with chronic hepatitis B infection based on risk calculators.
Review the assessment of hepatic fibrosis using noninvasive testing in patients with chronic hepatitis B infection.
Summarize the impact of MASLD/ MASH in patients with chronic hepatitis B infection in terms of clinical outcomes.